Poster: ALL-132: Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): PhALLCON Study
作者
Elias Joseph Jabbour,Giovanni Martinelli,Marco Vignetti,Hagop M. Kantarjian,David Gómez‐Almaguer,Yosuke Minami,Hervé Dombret,Meliessa G. Hennessy,Alexander Vorog,Bingxia Wang,Josep‐María Ribera